Stay updated on Azacitidine + Pembrolizumab in AML Clinical Trial
Sign up to get notified when there's something new on the Azacitidine + Pembrolizumab in AML Clinical Trial page.

Latest updates to the Azacitidine + Pembrolizumab in AML Clinical Trial page
- Check6 days agoChange DetectedThe study page now indicates that enrollment has closed ('No longer looking for participants'). It also adds new sections and headings for user guidance and study details (How to Read a Study Record, Common Questions, How to Join a Study, Intervention/Treatment), reflecting a reorganized information layout.SummaryDifference0.4%

- Check13 days agoChange DetectedNew revision entry v3.5.5 appears in the history and the old revision v3.5.4 is removed. This indicates an update to the site's underlying version rather than changes to trial content.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, indicating a newer version of the page. This change is an internal version update and does not modify the visible content or user-facing features.SummaryDifference0.1%

- Check56 days agoChange DetectedUpdated the page’s software/revision version indicator from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check63 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check92 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Azacitidine + Pembrolizumab in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine + Pembrolizumab in AML Clinical Trial page.